To identify cancer cells that would provide a robust ALT+ tumor xenograft model, we compared the ability of various ALT+ cancer cell lines to form macroscopic tumors in immunodeficient NSG mice within a time frame compatible with possible future drug testing experiments. The gene discussed is GPT; the disease is neoplasm.